BMCS Antibody–Drug Conjugates
Event
BMCS Antibody – Drug Conjugates
Date
Thursday 19th November 2026
Place
GSK, Stevenage, UK
Important links and downloads
Social Media – #BMCSADCs
Click here to submit your abstract
Click here to register for the meeting
Synopsis
Following the success of the BMCS Hot Topics Antibody-drug conjugates meeting, the BMCS are organising an in-person Antibody-Drug Conjugates meeting.
Antibody-Drug Conjugates (ADCs), alongside other targeted modalities, effectively enrich target tissues with potent payloads unsuitable for systemic administration. With several recent clinical successes, the number of new ADCs approaching the clinic is rapidly increasing. This meeting aims to highlight the technological advancements and innovations driving these ADCs, while addressing the challenges and opportunities within the field. The meeting will feature speakers from industry and academia who are at the forefront of ADC design.
Registration
Registration fees are below. Please note that these fees are excluding VAT, and VAT will be added on at checkout at the end of completing the registration form.
RSC Member: £165
Non-Member: £200
RSC Student Member: £85
Student Non-Member: £100
Please click here to register.
Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC, please follow this RSC link.
Bursaries
The RSC-BMCS is offering a small number of bursaries to attend the meeting in person. Applications are open to PhD and post-doctoral applicants studying at academic institutions or non-profit institutions. Preference will be given to members of the RSC-BMCS. Bursary applications are also invited from RSC members who are of working age, but currently unemployed, and from those who may have difficulty in funding themselves or whose organisations may have difficulty in funding their attendance. The bursary value for this event is up to £350 and applicants have to fill out a bursary application form. The deadline for bursary applications is Friday 11th September 2026.
Please click here for the RSC-BMCS bursary application form.
Abstracts
Abstract submission is open for oral, flash talk and posters and poster only abstracts. The deadline for submission is Friday 4th September 2026. Please click here to submit your abstract.
Sponsorship/Exhibition Opportunities
Exhibition stand package includes (£750 excluding VAT):
– A table and chairs
– Access to electricity
– Logo inclusion on the website, in the delegate handbook and rolling slides
– Promotional A4 page in the delegate handbook
– One stand personnel
Please click here to book your exhibition stand package.
Confirmed Speakers
Bradley Pentelute, MIT
David Battersby, GSK
Christian Hackenberger, FMP Berlin and the Humboldt University Berlin
P5-labeling for Generating Highly Efficacious Antibody-Conjugates for Cancer Therapy
Andrea Hernandez, Zymeworks
George Procopiou, Valink Therapeutics
Next-generation bispecific ADCs: discovery, challenges, and outlook
Exhibitors
Sponsors
Supported by
Organising Committee
Sharan Bagal, AstraZeneca
Maximillian Lee, AstraZeneca
Karina Chan, GSK
Vijay Chudasama, University College London
Christine Sutton, Charles River
Sree Kesavan, AstraZeneca
Mahri Park, GSK
Secretariat Contact
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail